Our data suggest that loss of arpin is a new hallmark of acute inflammation in ulcerative colitis and that the Arp2/3 complex may serve as a therapeutic target to treat inflammatory bowel diseases. The gene discussed is ARPIN; the disease is inflammatory bowel disease.